The possibility of perindopril in angioprotective in patients with metabolic syndrome after combination therapy with a thiazide diuretic | Zendy

С. В. Недогода | Zendy; В. О. Смирнова | Zendy; V Yu Khripaeva | Zendy; Р. В. Палашкин | Zendy; A. A. Ledyaeva | Zendy; Е. В. Чумачок | Zendy; A. S. Salasyuk | Zendy

Open Access

The possibility of perindopril in angioprotective in patients with metabolic syndrome after combination therapy with a thiazide diuretic

Author(s) -

С. В. Недогода,

В. О. Смирнова,

V Yu Khripaeva,

Р. В. Палашкин,

A. A. Ledyaeva,

Е. В. Чумачок,

A. S. Salasyuk

Publication year - 2016

Publication title -

systemic hypertension

Language(s) - English

Resource type - Journals

eISSN - 2542-2189

pISSN - 2075-082X

DOI - 10.26442/sg29121

Subject(s) - hydrochlorothiazide , perindopril , metabolic syndrome , medicine , thiazide , diuretic , combination therapy , losartan , cardiology , endocrinology , blood pressure , renin–angiotensin system , obesity

Aim. To assess the possibility of monotherapy with perindopril after transferring from combination therapy with losartan and hydrochlorothiazide with respect to correction of the anthropometric, metabolic parameters, premature vascular aging and vascular elasticity in patients with metabolic syndrome. Material and methods. Held open prospective controlled study of 50 patients with metabolic syndrome (IDF, 2005), which reached BP

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research